Big Easy Weight Loss Fees: Zero Membership, but Medication Prepay

Last reviewed: September 23, 2026 Last updated: September 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Big Easy Weight Loss charges zero membership fees. Medication costs $399 for a 12-week supply of compounded semaglutide or $499 for compounded tirzepatide, prepaid at advertised introductory rates (captured September 4, 2026). The company's homepage also displays a $495 list price for semaglutide, but the relationship between that figure and the $399 promotional bundle—and whether the promotional rate renews automatically—is not documented in public checkout flows or terms-of-service pages. No standard refill rate for tirzepatide is published. Readers planning 12-month treatment should confirm renewal pricing, dose-tier variations, and cancellation terms before the first charge.

At-a-glance: Big Easy Weight Loss vs PlexusDx

Breaking down Big Easy's pricing: introductory bundles vs ongoing rates

Big Easy Weight Loss advertises a 12-week prepaid introductory rate of $399 for compounded semaglutide injection—roughly $133 per month—and $499 for compounded tirzepatide injection, roughly $166.33 per month (pricing page captured September 4, 2026). No separate membership, visit, or program fee is charged; the prepaid cycle covers medication and program access together.

Two pricing signals create uncertainty about ongoing costs. First, the company's homepage displays a $495 list price for semaglutide alongside the $399 promotional bundle. The relationship between these figures—whether $495 represents a standard refill rate, a different dose tier, or a non‑promotional 12‑week cycle—is not explained in captured checkout or terms pages. Second, no standard refill rate for tirzepatide is documented anywhere in public‑facing materials. The pricing page notes that "starter discount and pharmacy variations may apply," and that fills are prorated for non‑12‑week periods, but it does not specify whether the advertised rates renew automatically or step up after the first cycle.

Prospective patients planning multi‑month treatment should confirm at checkout whether the $399 semaglutide rate renews at each 12‑week interval, what the ongoing tirzepatide rate will be after the first $499 cycle, and how dose escalation affects pricing. Without published refill rates, a 12‑month budget forecast carries material uncertainty.

12-month cost comparison: prepaid cycles vs month-to-month flexibility

Assuming Big Easy's advertised introductory rates renew every 12 weeks (an assumption not verified in captured terms), a full year of compounded semaglutide would cost $1,596 ($399 × four cycles, roughly $133/month—our calculation). A year of compounded tirzepatide at the advertised rate would cost $1,996 ($499 × four cycles, roughly $166.33/month—our calculation). Those figures represent a substantial discount against many month‑to‑month telehealth plans—if the promotional rate persists.

PlexusDx's month-to-month semaglutide injection costs $189 per month with zero prepayment, yielding a 12‑month total of $2,268 (our calculation). Month‑to‑month tirzepatide costs $289 per month, or $3,468 annually (our calculation). Patients who prepay six months with PlexusDx bring semaglutide down to $149 per month ($1,788 per year, our calculation) and tirzepatide to $249 per month ($2,988 per year, our calculation). Because Big Easy's standard refill rates are not documented, a true like‑for‑like comparison requires verifying whether the $399/$499 promotional rates renew or step up after the first cycle.

All 12-month totals and effective-monthly figures are our calculations. Big Easy figures assume the advertised introductory rates renew; standard refill rates are not documented.

What's included in Big Easy's medication cost

Big Easy's advertised 12-week prepaid cycle bundles compounded medication and program access together—no separate line items for provider visits, care coordination, or shipping are documented. The pricing page states "Medication + Program" as the package description (captured September 4, 2026). Fills are prorated for non‑12‑week periods, and the site notes that pharmacy variations may apply, indicating that medication sourcing spans multiple compounding facilities. No prescription‑transfer policy, onboarding lab requirements, or dose‑titration protocol is detailed in captured materials.

PlexusDx bundles the online provider visit, prescription, compounded medication, and standard shipping into a single monthly or prepaid rate. The same price applies at every dose—patients escalating from 0.25 mg to 2.4 mg semaglutide pay $189 per month on the month‑to‑month plan throughout the titration schedule. Licensed clinicians review every intake within one business day; no charge posts until approval.

Strengths and gaps in Big Easy's pricing model

Strengths

• Zero membership fees: No separate subscription, platform fee, or care-coordination charge appears in captured pricing (September 4, 2026).
• Low advertised introductory rates: At roughly $133–$166.33 per month over 12‑week prepaid cycles, Big Easy's promotional bundles undercut many telehealth competitors on first‑cycle cost.
• Bundled program and medication: A single prepaid charge covers both medication and program access, simplifying billing for patients who prefer lump‑sum budgeting.

Gaps and documentation limits

• Unclear refill pricing: The homepage displays a $495 list price for semaglutide alongside the $399 promotional bundle, but the relationship between the two—and whether the promotional rate renews—is not explained in captured checkout or terms pages. No standard refill rate for tirzepatide is documented.
• No published cancellation or refund policy: Patients committing to a 12‑week prepaid cycle have no documented recourse if they experience intolerable side effects, achieve goal weight early, or need to switch medications mid‑cycle.
• Dose‑tier pricing variations: The pricing page disclaims that "starter discount and pharmacy variations may apply," suggesting that higher doses or different pharmacy sources may change the effective rate—but no dose‑specific pricing table is published.
• Prorated fills: The note that fills are prorated for non‑12‑week periods implies flexibility, but the mechanics—whether proration applies to early cancellation, dose changes, or delivery delays—are not detailed.

Choose Big Easy Weight Loss if…

• You're comfortable prepaying three months of medication up front and can confirm renewal pricing at checkout.
• The advertised $399 semaglutide or $499 tirzepatide introductory rate fits your immediate budget and you plan to verify standard refill costs before committing to a second cycle.
• You prefer a bundled medication-and-program package with zero separate membership fees.
• You're starting GLP‑1 therapy and prioritize the lowest first‑cycle cost over month‑to‑month flexibility or published refund terms.

Choose PlexusDx if…

• You want predictable, published pricing at every billing cadence—month‑to‑month ($189 semaglutide, $289 tirzepatide), 3‑month prepaid, or 6‑month prepaid—with no promotional introductory rate that may step up after the first cycle.
• The same‑price‑at‑every‑dose model matters: you're planning dose escalation from 0.25 mg to 2.4 mg semaglutide (or 2.5 mg to 15 mg tirzepatide) and want cost certainty throughout titration.
• Month‑to‑month flexibility outweighs a lower prepaid introductory rate: you prefer the option to pause, adjust medication, or cancel without forfeiting a prepaid 12‑week supply.
• Service‑quality verification is a priority: PlexusDx holds a 4.3‑star Trustpilot rating with 79% five‑star reviews and 83% four‑star or higher (captured September 9, 2026).

Methodology and freshness

Big Easy Weight Loss pricing, membership-fee structure, and program inclusions were captured from the company's homepage and pricing page on September 4, 2026. The $399 semaglutide and $499 tirzepatide figures are labeled as advertised introductory rates; the $495 homepage list price for semaglutide is also documented. No checkout verification, terms‑of‑service capture, or standard refill‑rate confirmation is included in this research cycle. PlexusDx pricing is current as of September 23, 2026, and is verified against live product pages. All 12‑month cost totals and effective‑monthly calculations in this article are our own work, derived from the documented per‑cycle or per‑month rates. The comparison assumes Big Easy's advertised rates renew every 12 weeks; readers planning long‑term treatment should confirm renewal pricing, dose‑tier variations, and cancellation terms at checkout before the first charge posts.

Frequently Asked Questions

Does Big Easy Weight Loss charge a membership fee separate from medication?

No. Big Easy bundles medication and program access into a single 12‑week prepaid charge with zero separate membership, visit, or platform fee documented in captured pricing materials (September 4, 2026).

What is Big Easy's standard refill rate after the introductory cycle?

The pricing page advertises a $399 12‑week introductory rate for semaglutide and $499 for tirzepatide, but it does not publish a standard refill rate for subsequent cycles. The homepage displays a $495 list price for semaglutide, though the relationship between that figure and the $399 promotional bundle is not explained. Confirm renewal pricing at checkout.

Can I cancel Big Easy mid‑cycle and get a refund if I experience side effects?

Big Easy's cancellation and refund policies are not documented in captured sources. Because the service operates on 12‑week prepaid cycles, patients should ask customer support about mid‑cycle cancellation terms, prorated refunds, and return procedures before committing to the first charge.

Does PlexusDx require prepayment, or can I pay month‑to‑month?

PlexusDx offers month‑to‑month billing at $189 for semaglutide injection and $289 for tirzepatide injection, with no prepayment required. Three‑month and six‑month prepaid plans are also available at discounted per‑month rates ($169 and $149 for semaglutide; $269 and $249 for tirzepatide).

Which provider has the lower 12‑month cost if I prepay?

If Big Easy's advertised $399 semaglutide rate renews every 12 weeks, the annual cost is $1,596 (our calculation). PlexusDx's six‑month prepaid semaglutide plan costs $1,788 per year (our calculation). For tirzepatide, Big Easy's advertised rate yields $1,996 annually versus PlexusDx's $2,988 on the six‑month plan. Confirm Big Easy's renewal rate at checkout to validate this comparison.

Sources

• Big Easy Weight Loss homepage and pricing page (captured September 4, 2026)
• PlexusDx product pages: semaglutide injection, tirzepatide injection (accessed September 23, 2026)
• PlexusDx Trustpilot profile (captured September 9, 2026; trustpilot.com/review/plexusdx.com)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.